Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04327596 · ClinicalTrials.gov registry record · NA
Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04327596 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 2 participants.
The verdict
NCT04327596, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patients who receive an early radiofrequency ablation will have fewer hospitalizations, unplanned office visits, and emergency room visits than those patients treated with medical therapy alone.
Interventions
- PROCEDURE RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2021-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04327596
The ClinicalTrials.gov registry entry for NCT04327596 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter is the first listed.
NCT04327596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04327596 about?
NCT04327596 is a clinical study titled "Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction". The purpose of this study is to determine if patients who receive an early radiofrequency ablation will have fewer hospitalizations, unplanned office visits, and emergency room visits than those patients treated with medical therapy alone.
What is the current status of trial NCT04327596?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2021-01-25. Estimated completion is 2021-09-21.
What interventions are being tested in trial NCT04327596?
The interventions under investigation include: RF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter (PROCEDURE).
Who is sponsoring clinical trial NCT04327596?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.